Hammond C, Roztocil E, Phipps R, Feldon S, Woeller C. Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor. PLoS ONE. 2019;14:e0222779 pubmed publisher

Derayea S, Tsujino H, Oyama Y, Ishikawa Y, Yamashita T, Uno T. Investigation on drug-binding in heme pocket of CYP2C19 with UV-visible and resonance Raman spectroscopies. Spectrochim Acta A Mol Biomol Spectrosc. 2019;209:209-216 pubmed publisher

Batista L, Lima G, de Almeida A, Magri L, Calvo T, Ferreira A, et al. Ulcer healing and mechanism(s) of action involved in the gastroprotective activity of fractions obtained from Syngonanthus arthrotrichus and Syngonanthus bisulcatus. BMC Complement Altern Med. 2015;15:391 pubmed publisher

Yu M, Lee C, Wang M, Tannock I. Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors. Cancer Sci. 2015;106:1438-47 pubmed publisher

Niece K, Boyd N, Akers K. In vitro study of the variable effects of proton pump inhibitors on voriconazole. Antimicrob Agents Chemother. 2015;59:5548-54 pubmed publisher

Périco L, Heredia Vieira S, Beserra F, de Cássia Dos Santos R, Weiss M, Resende F, et al. Does the gastroprotective action of a medicinal plant ensure healing effects? An integrative study of the biological effects of Serjania marginata Casar. (Sapindaceae) in rats. J Ethnopharmacol. 2015;172:312-24 pubmed publisher

Blackler R, De Palma G, Manko A, Da Silva G, Flannigan K, Bercik P, et al. Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID. Am J Physiol Gastrointest Liver Physiol. 2015;308:G994-1003 pubmed

Haruma K, Kinoshita Y, Sakamoto S, Sanada K, Hiroi S, Miwa H. Lifestyle factors and efficacy of lifestyle interventions in gastroesophageal reflux disease patients with functional dyspepsia: primary care perspectives from the LEGEND study. Intern Med. 2015;54:695-701 pubmed publisher

Areche C, Benites J, Cornejo A, Ruiz L, García Beltrán O, Simirgiotis M, et al. Seco-taondiol, an unusual meroterpenoid from the Chilean seaweed Stypopodium flabelliforme and its gastroprotective effect in mouse model. Mar Drugs. 2015;13:1726-38 pubmed publisher

Buckley M, Park A, Anderson C, Barletta J, Bikin D, Gerkin R, et al. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients. Am J Med. 2015;128:905-13 pubmed publisher

Becker K, Salar Behzadi S, Zimmer A. Solvent-free melting techniques for the preparation of lipid-based solid oral formulations. Pharm Res. 2015;32:1519-45 pubmed publisher

Liu F, Shokrollahi H. In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer. Int J Pharm. 2015;485:152-9 pubmed publisher

Miwa H, Haruma K, Sakamoto S, Sanada K, Hiroi S, Kinoshita Y. Demography and treatment response in patients with predominant non-erosive reflux disease or functional dyspepsia. J Gastroenterol Hepatol. 2015;30:834-41 pubmed publisher

Kim J, Chung M, Chung C, Park H, Ryang D, Myung D, et al. The need for second-look endoscopy to prevent delayed bleeding after endoscopic submucosal dissection for gastric neoplasms: a prospective randomized trial. Gut Liver. 2014;8:480-6 pubmed publisher

Novotna A, Dvorak Z. Omeprazole and lansoprazole enantiomers induce CYP3A4 in human hepatocytes and cell lines via glucocorticoid receptor and pregnane X receptor axis. PLoS ONE. 2014;9:e105580 pubmed publisher

Jung S, Park C, Kim E, Shin S, Chung H, Lee H, et al. Preventing metachronous gastric lesions after endoscopic submucosal dissection through Helicobacter pylori eradication. J Gastroenterol Hepatol. 2015;30:75-81 pubmed publisher

Areche C, Sepúlveda B, San Martin A, García Beltrán O, Simirgiotis M, Cañete A. An unusual mulinane diterpenoid from the Chilean plant Azorella trifurcata (Gaertn) Pers. Org Biomol Chem. 2014;12:6406-13 pubmed publisher

Novotna A, Srovnalova A, Svecarova M, Korhonova M, Bartonkova I, Dvorak Z. Differential effects of omeprazole and lansoprazole enantiomers on aryl hydrocarbon receptor in human hepatocytes and cell lines. PLoS ONE. 2014;9:e98711 pubmed publisher

Yamashita Y, Ueyama T, Nishi T, Yamamoto Y, Kawakoshi A, Sunami S, et al. Nrf2-inducing anti-oxidation stress response in the rat liver--new beneficial effect of lansoprazole. PLoS ONE. 2014;9:e97419 pubmed publisher

Iguchi K, Hashimoto M, Kubota M, Yamashita S, Nakamura M, Usui S, et al. Effects of 14 frequently used drugs on prostate-specific antigen expression in prostate cancer LNCaP cells. Oncol Lett. 2014;7:1665-1668 pubmed

Bergström C, Andersson S, Fagerberg J, Ragnarsson G, Lindahl A. Is the full potential of the biopharmaceutics classification system reached?. Eur J Pharm Sci. 2014;57:224-31 pubmed publisher

Xu Y, Mao L, Li X, Wang Y, Wei P. Dissolution improvement of poorly water-soluble drug by cogrinding method using jar mill. Pak J Pharm Sci. 2013;26:495-502 pubmed

Navarro Rodriguez T, Silva F, Barbuti R, Mattar R, Moraes Filho J, De Oliveira M, et al. Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study. BMC Gastroenterol. 2013;13:56 pubmed publisher

Matsumoto T, Inokuma T, Imai Y. Education and imaging. Gastrointestinal: colonic mucosa-associated lymphoid tissue lymphoma regressed by levofloxacin. J Gastroenterol Hepatol. 2013;28:750 pubmed publisher

Badiola N, Alcalde V, Pujol A, Munter L, Multhaup G, Lleo A, et al. The proton-pump inhibitor lansoprazole enhances amyloid beta production. PLoS ONE. 2013;8:e58837 pubmed publisher

Malfertheiner P. [Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance]. Dtsch Med Wochenschr. 2013;138:628 pubmed publisher

Konijeti G, Deshpande V, Bunker C. An unusual case of chronic diarrhea. Lansoprazole-induced microscopic colitis. Gastroenterology. 2013;144:696, 857 pubmed publisher

Peura D, Pilmer B, Hunt B, Mody R, Perez M. The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole. Aliment Pharmacol Ther. 2013;37:810-8 pubmed publisher

Kim J, Sung I, Hong S, Lee S, Park H, Shim C. Is the proton pump inhibitor test helpful in patients with laryngeal symptoms?. Dig Dis Sci. 2013;58:1663-7 pubmed publisher

Morgan D, Torres J, Sexton R, Herrero R, Salazar Martinez E, Greenberg E, et al. Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA. 2013;309:578-86 pubmed publisher

Mahabaleshwarkar R, Yang Y, Datar M, Bentley J, Strum M, Banahan B, et al. Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients. Curr Med Res Opin. 2013;29:315-23 pubmed publisher

Hanneken A, Babai N, Thoreson W. Oral proton pump inhibitors disrupt horizontal cell-cone feedback and enhance visual hallucinations in macular degeneration patients. Invest Ophthalmol Vis Sci. 2013;54:1485-9 pubmed publisher

Liou J, Chen C, Chen M, Chen C, Chang C, Fang Y, et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial. Lancet. 2013;381:205-13 pubmed publisher

Chularojanamontri L, Jiamton S, Manapajon A, Suvanasuthi S, Kulthanan K, Dhana N, et al. Cutaneous reactions to proton pump inhibitors: a case-control study. J Drugs Dermatol. 2012;11:e43-7 pubmed

Tham S, Rogers I, Samuel K, Singh A, Ong K. Does oral lansoprazole really reduce gastric acidity in VLBW premature neonates?. Med J Malaysia. 2012;67:284-8 pubmed

Lu Y, Guo T, Qi J, Zhang J, Wu W. Enhanced dissolution and stability of lansoprazole by cyclodextrin inclusion complexation: preparation, characterization, and molecular modeling. AAPS PharmSciTech. 2012;13:1222-9 pubmed publisher

Satoh H. Discovery of lansoprazole and its unique pharmacological properties independent from anti-secretory activity. Curr Pharm Des. 2013;19:67-75 pubmed

Lim Y, Phan T, Dial E, Graham D, Lichtenberger L. In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine. Digestion. 2012;86:171-7 pubmed publisher

Kiffer Moreira T, Yadav M, Zhu D, Narisawa S, Sheen C, Stec B, et al. Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification. J Bone Miner Res. 2013;28:81-91 pubmed publisher

Ieiri I, Fukae M, Maeda K, Ando Y, Kimura M, Hirota T, et al. Pharmacogenomic/pharmacokinetic assessment of a four-probe cocktail for CYPs and OATPs following oral microdosing. Int J Clin Pharmacol Ther. 2012;50:689-700 pubmed publisher

Chung J, Jung Y, Kim Y, Kwon K, Kim J, Lee J, et al. Ten-day sequential versus triple therapy for Helicobacter?pylori eradication: a prospective, open-label, randomized trial. J Gastroenterol Hepatol. 2012;27:1675-80 pubmed publisher

Rajendiran S, Zachariah B, Hamide A. Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment. Saudi J Gastroenterol. 2012;18:252-6 pubmed publisher

Nguyen T, Bengtsson C, Yin L, Nguyen G, Hoang T, Phung D, et al. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance. Helicobacter. 2012;17:319-25 pubmed publisher

Mosli H, Dennis A, Kocha W, Asher L, van Uum S. Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects. J Clin Endocrinol Metab. 2012;97:E1731-5 pubmed publisher

. [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors]. Ter Arkh. 2012;84:16-21 pubmed

Chai G, Governale L, McMahon A, Trinidad J, Staffa J, Murphy D. Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics. 2012;130:23-31 pubmed publisher

Funakoshi R, Yokoyama H, Kawai N, Kobayashi K, Ueno F, Yamada Y. [Effect of pharmaceutical care in the diagnosis of Helicobacter pylori infection using 13C-urea breath test]. Yakugaku Zasshi. 2012;132:601-7 pubmed

Bödvarsdottir T, Hove K, Gotfredsen C, Pridal L, Vaag A, Karlsen A, et al. Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes. Diabetologia. 2010;53:2220-3 pubmed publisher

Barradell L, Faulds D, McTavish D. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs. 1992;44:225-50 pubmed